GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (FRA:0E81) » Definitions » Shiller PE Ratio

Advanced Proteome Therapeutics (FRA:0E81) Shiller PE Ratio : (As of Jun. 17, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Advanced Proteome Therapeutics Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Advanced Proteome Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Advanced Proteome Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Shiller PE Ratio Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Advanced Proteome Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Advanced Proteome Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Proteome Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's Shiller PE Ratio falls into.



Advanced Proteome Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Advanced Proteome Therapeutics's E10 for the quarter that ended in Apr. 2023 is calculated as:

For example, Advanced Proteome Therapeutics's adjusted earnings per share data for the three months ended in Apr. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Apr. 2023 (Change)*Current CPI (Apr. 2023)
=0/123.5712*123.5712
=0.000

Current CPI (Apr. 2023) = 123.5712.

Advanced Proteome Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201307 0.000 97.261 0.000
201310 0.000 97.182 0.000
201401 -0.147 97.261 -0.187
201404 0.013 98.920 0.016
201407 0.074 99.315 0.092
201410 -0.009 99.473 -0.011
201501 -0.017 98.209 -0.021
201504 -0.026 99.710 -0.032
201507 0.000 100.579 0.000
201510 -0.010 100.500 -0.012
201601 -0.013 100.184 -0.016
201604 -0.011 101.370 -0.013
201607 -0.055 101.844 -0.067
201610 -0.013 102.002 -0.016
201701 -0.017 102.318 -0.021
201704 -0.014 103.029 -0.017
201707 -0.046 103.029 -0.055
201710 -0.009 103.424 -0.011
201801 -0.036 104.056 -0.043
201804 0.024 105.320 0.028
201807 -0.022 106.110 -0.026
201810 -0.017 105.952 -0.020
201901 0.009 105.557 0.011
201904 -0.002 107.453 -0.002
201907 -0.012 108.243 -0.014
201910 -0.001 107.927 -0.001
202001 -0.009 108.085 -0.010
202004 -0.005 107.216 -0.006
202007 -0.009 108.401 -0.010
202010 -0.009 108.638 -0.010
202101 0.001 109.192 0.001
202104 -0.042 110.851 -0.047
202107 0.000 112.431 0.000
202110 0.000 113.695 0.000
202201 0.018 114.801 0.019
202204 -0.009 118.357 -0.009
202207 -0.010 120.964 -0.010
202210 -0.010 121.517 -0.010
202301 -0.009 121.596 -0.009
202304 0.000 123.571 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Advanced Proteome Therapeutics  (FRA:0E81) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Advanced Proteome Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Proteome Therapeutics (FRA:0E81) Business Description

Traded in Other Exchanges
Address
8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (FRA:0E81) Headlines

No Headlines